wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
   Journals
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Archive
     Editorial staff
     Editorial board
     For authors
     Subscription
Otorhinolaryngology
Allergology Review



 Search in articles:
  Authority of Polish Society of Allergology




vol 20. no 4. December 2015  
 TABLE OF CONTENT

 Review articles
The qualification of severe asthma patients to the treatment with use of omalizumab - the guide for doctors
Iwona Damps-Konstańska

Since 2013 in Poland it has been possible to treat patients with severe allergic
asthma with omalizumab – a monoclonal antibody. The treatment
is reimbursed by the National Health Found. The article explains the rules
applied in qualifying patients to the treatment with omalizumab. Moreover,
indications, contraindications and rules for monitoring patients with
severe asthma treated with omalizumab are presented.

keywords: omalizumab, ciężka astma, refundacja przez NarodowyFundusz Zdrowia,omalizumab, severe asthma, the reimbursement byNational Health Found

pages: from 215 to 217



estimated time of download (61 kB)
broadband speed:561282565121024[kbps]
time:135321[sec]


You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.


Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.